DrugPatentWatch Database Preview
Profile for Australia Patent: 2006325244
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Australia Patent: 2006325244
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jul 6, 2027 | Leo Labs | PICATO | ingenol mebutate |
Start Trial | Dec 18, 2026 | Leo Labs | PICATO | ingenol mebutate |
Start Trial | Dec 18, 2026 | Leo Labs | PICATO | ingenol mebutate |
Start Trial | Dec 18, 2026 | Leo Labs | PICATO | ingenol mebutate |
Start Trial | Dec 18, 2026 | Leo Labs | PICATO | ingenol mebutate |
Start Trial | Dec 18, 2026 | Leo Labs | PICATO | ingenol mebutate |
Start Trial | Dec 18, 2026 | Leo Labs | PICATO | ingenol mebutate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |